Well Referenced

Tag: macular degeneration

Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Age-Related Macular Degeneration

This 2020 study evaluated the safety and efficacy of autologous bone marrow-derived stem cells (BMSCs) in 32 eyes from patients aged 69–90 with dry age-related macular degeneration (AMD). BMSCs were administered via retrobulbar, subtenons, intravitreal, subretinal, and intravenous routes. After treatment, 63% of eyes showed improvement in visual acuity, 34%

Read More »
June 26, 2025 No Comments

Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Stargardt Disease

The SCOTS and SCOTS2 trials evaluated the safety and efficacy of autologous bone marrow-derived stem cells (BMSCs) in 34 eyes from patients with Stargardt Disease. BMSCs were administered via retrobulbar, subtenons, intravitreal, subretinal, and intravenous routes. After one year, 61.8% of eyes showed visual improvement, 23.5% remained stable, and 14.7%

Read More »
June 26, 2025 No Comments

Phytochemicals and age-related eye diseases

This review article explores the role of various phytochemicals in preventing and managing age-related eye diseases, including cataracts, glaucoma, and age-related macular degeneration (AMD). Compounds such as lutein, zeaxanthin, green tea catechins, anthocyanins, resveratrol, and Ginkgo biloba are highlighted for their antioxidant, anti-inflammatory, and neuroprotective properties. Evidence from observational and

Read More »
June 26, 2025 No Comments